Hattersheim, Germany

Walter D Urckheimer

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter D Urckheimer. Retrieved from https://idiyas.com/inventor/walter-d-urckheimer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter D Urckheimer: Innovator in Corticosteroid Chemistry

Introduction

Walter D Urckheimer is a notable inventor based in Hattersheim, Germany. He has made significant contributions to the field of corticosteroid chemistry. His work has led to the development of innovative compounds that have potential applications in medicine.

Latest Patents

Walter D Urckheimer holds a patent for "Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters." This patent describes corticosteroid compounds characterized by specific chemical structures. The compounds are obtained by reacting a compound with an activated carboxylic acid, showcasing Urckheimer's expertise in organic chemistry.

Career Highlights

Throughout his career, Urckheimer has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has contributed to advancements in corticosteroid formulations, enhancing their efficacy and safety.

Collaborations

Urckheimer has collaborated with esteemed colleagues such as Ulrich Stache and Hans-Georg Alpermann. These collaborations have fostered a productive environment for innovation and research in corticosteroid chemistry.

Conclusion

Walter D Urckheimer's contributions to the field of corticosteroid chemistry are noteworthy. His patent and collaborations reflect his commitment to advancing medical science. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…